Alaunos Therapeutics, Inc.
TCRT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,058 | $16,971 | $140,946 | $233,695 |
| - Cash | $1,091 | $6,062 | $39,058 | $76,054 |
| + Debt | $0 | $0 | $20,069 | $30,094 |
| Enterprise Value | $1,967 | $10,909 | $121,957 | $187,735 |
| Revenue | $10 | $5 | $2,922 | $398 |
| % Growth | 100% | -99.8% | 634.2% | – |
| Gross Profit | $10 | -$4,798 | $2,922 | $398 |
| % Margin | 100% | -95,960% | 100% | 100% |
| EBITDA | -$4,677 | -$30,904 | -$31,817 | -$74,965 |
| % Margin | -46,770% | -618,080% | -1,088.9% | -18,835.4% |
| Net Income | -$4,679 | -$35,140 | -$37,730 | -$78,751 |
| % Margin | -46,790% | -702,800% | -1,291.2% | -19,786.7% |
| EPS Diluted | -2.92 | -21.97 | -25.97 | -53.8 |
| % Growth | 86.7% | 15.4% | 51.7% | – |
| Operating Cash Flow | -$4,971 | -$30,142 | -$29,232 | -$61,468 |
| Capital Expenditures | $0 | -$197 | -$216 | -$3,323 |
| Free Cash Flow | -$4,971 | -$30,339 | -$29,448 | -$64,791 |